Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations-Reference-Cited by-同舟云学术

Ivermectin systemic availability in adult volunteers treated with different oral pharmaceutical formulations

Published:2023-04 Issue: Volume:160 Page:114391
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Ceballos L.,Alvarez L.,Lifschitz A.,Lanusse C.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference64 articles.

1. Ivermectin: a potent new antiparasitic agent;Campbell;Science,1983

2. Merck's new drug free to WHO for river blindness programme;Lindley;Nature,1987

3. Ivermectin: a review of efficacy and safety;Campbell;J. Vet. Pharm. Ther.,1984

4. Summary of global update on implementation of preventive chemotherapy against neglected tropical diseases in 2019;Wkly. Epiemiol. Rec.,2020

5. World Health Organization, 21st Model List of Essential Medicines, Geneva, Switzerland, 2019b, 2021. Available at: 〈https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06〉.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use;The Journal of Clinical Pharmacology;2024-05-30

2. Albendazole metabolites excretion in human saliva as a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs;Scientific Reports;2024-03-15

3. Albendazole metabolites excretion in human saliva: a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs;2023-10-10

4. Development of ivermectin orally disintegrating tablets using factorial design: In-vitro evaluation and in vivo absorption pattern in rats;Journal of Drug Delivery Science and Technology;2023-09